Table 6 Top ten cited articles on carbapenem resistance (1986–2015)
From: Bibliometric analysis of global scientific research on carbapenem resistance (1986–2015)
SCR | Authors | Title | Year | Source title | Number of citations |
|---|---|---|---|---|---|
1st | Kumarasamy et al. [34] | Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study | 2010 | The Lancet Infectious Diseases | 1212 |
2nd | Yong et al. [41] | Characterization of a new metallo-β-lactamase gene, bla NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India | 2009 | Antimicrobial Agents and Chemotherapy | 835 |
3rd | Nordmann et al. [36] | The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria | 2009 | The Lancet Infectious Diseases | 689 |
4th | Yigit et al. [40] | Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae | 2001 | Antimicrobial Agents and Chemotherapy | 673 |
5th | Nordmann et al. [37] | Global spread of carbapenemase producing Enterobacteriaceae | 2011 | Emerging Infectious Diseases | 643 |
6th | Poirel and Nordmann [38] | Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology | 2006 | Clinical Microbiology and Infection | 474 |
7th | Woodford et al. [39] | Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. | 2006 | International Journal of Antimicrobial Agents | 427 |
8th | Lauretti et al. [35] | Cloning and characterization of bla(VIM), a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate | 1999 | Antimicrobial Agents and Chemotherapy | 395 |
9th | Bratu et al. [33] | Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium | 2005 | Archives of Internal Medicine | 372 |
10th | Bradford et al. [32] | Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein | 1997 | Antimicrobial Agents and Chemotherapy | 358 |